Hanna Lesch

Chief Technology Officer • Exothera

Hanna has dedicated her career to gene therapy and has held several director positions including leading research and development at FKD Therapies, Kuopio Center for Cell & Gene Therapy and Finvector. Hanna holds several member and executive board positions in industry associations, is an adjunct professor at the University of Eastern Finland and is a frequent speaker at cell and gene therapy industry events.

Also Speaking

Michalle Adkins

Director, Life Sciences Strategy • Emerson

Jeff Masten

Chief Operating Officer • Theragent

Fernanda Masri

Head of Manufacturing Innovation • Cell and Gene Therapy Catapult

Event Info


Post-Event Report

Download the post-event report for Advanced Therapies Week 2023.

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.